{"title":"针对COVID-19的适应性免疫","authors":"U. Shrestha","doi":"10.3126/jaim.v9i2.32811","DOIUrl":null,"url":null,"abstract":"The elderly patients, males more than females, smokers, and the patients with co-morbidities, such as hypertension, diabetes, cardiac disease, chronic kidney disease, obesity, immunocompromised state, liver disease, chronic underlying lung disease and cancer are more vulnerable for the severe COVID-19 disease. Several laboratory markers such as neutrophillymphocyte ratio, D-dimer, procalcitonin, ferritin, C-reactive protein (CRP), and pro-inflammatory interleukins can also help in predicting the severity of the disease.4","PeriodicalId":75443,"journal":{"name":"Advances in internal medicine","volume":"9 1","pages":"44-46"},"PeriodicalIF":0.0000,"publicationDate":"2020-11-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Adaptive immunity against COVID-19\",\"authors\":\"U. Shrestha\",\"doi\":\"10.3126/jaim.v9i2.32811\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"The elderly patients, males more than females, smokers, and the patients with co-morbidities, such as hypertension, diabetes, cardiac disease, chronic kidney disease, obesity, immunocompromised state, liver disease, chronic underlying lung disease and cancer are more vulnerable for the severe COVID-19 disease. Several laboratory markers such as neutrophillymphocyte ratio, D-dimer, procalcitonin, ferritin, C-reactive protein (CRP), and pro-inflammatory interleukins can also help in predicting the severity of the disease.4\",\"PeriodicalId\":75443,\"journal\":{\"name\":\"Advances in internal medicine\",\"volume\":\"9 1\",\"pages\":\"44-46\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2020-11-09\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Advances in internal medicine\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.3126/jaim.v9i2.32811\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Advances in internal medicine","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.3126/jaim.v9i2.32811","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
The elderly patients, males more than females, smokers, and the patients with co-morbidities, such as hypertension, diabetes, cardiac disease, chronic kidney disease, obesity, immunocompromised state, liver disease, chronic underlying lung disease and cancer are more vulnerable for the severe COVID-19 disease. Several laboratory markers such as neutrophillymphocyte ratio, D-dimer, procalcitonin, ferritin, C-reactive protein (CRP), and pro-inflammatory interleukins can also help in predicting the severity of the disease.4